I agree that this site is using cookies. You can find further informations here.
X
Rendo, Veronica
49  results:
Search for persons X
?
1

DIPG-70. NQO1 AS A RESISTANCE DRIVER AND THERAPEUTIC TARGET..:

Lupien, Leslie E ; Morin, Eric ; Zhang, Daren F...
Neuro-Oncology.  26 (2024)  Supplement_4 - p. 0-0 , 2024
Link: https://doi.org/10.1093/..
 
?
2

Comparison of high-throughput single-cell RNA-seq methods f..:

Gezelius, Henrik ; Enblad, Anna Pia ; Lundmark, Anders...
NAR Genomics and Bioinformatics.  6 (2024)  1 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
3

HGG-03. TRUNCATING MUTATIONS IN PPM1D COOPERATE WITH PI3K A..:

Kebede, Adam F ; Morin, Eric ; Kundu, Ipsita...
Neuro-Oncology.  26 (2024)  Supplement_4 - p. 0-0 , 2024
Link: https://doi.org/10.1093/..
 
?
4

Cancer aneuploidies are shaped primarily by effects on tumo..:

Shih, Juliann ; Sarmashghi, Shahab ; Zhakula-Kostadinova, Nadja...
Nature.  619 (2023)  7971 - p. 793-800 , 2023
Link: https://doi.org/10.1038/..
 
?
5

RTID-05. SURGICAL WINDOW OF OPPORTUNITY TRIAL REVEALS MECHA..:

Rendo, Veronica ; Lee, Eudocia ; Bossi, Connor...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v259-v259 , 2023
Link: https://doi.org/10.1093/..
 
?
6

EXTH-19. OPTIMIZING MDM2 INHIBITION FOR THE TREATMENT OF GL..:

Rendo, Veronica ; Lee, Eudocia ; Khuu, Nicholas...
Neuro-Oncology.  24 (2022)  Supplement_7 - p. vii213-vii213 , 2022
Link: https://doi.org/10.1093/..
 
?
7

Enhanced cytotoxicity of a novel family of ATPase inhibitor..:

Zhang, Xiaonan ; Akcan, Ece ; Correia, Mario...
Biochemical Pharmacology.  203 (2022)  - p. 115184 , 2022
Link: https://doi.org/10.1016/..
 
?
8

CTNI-26. SURGICAL WINDOW OF OPPORTUNITY TRIAL OF NAVTEMADLI..:

Lee, Eudocia ; Rudek, Michelle ; Rendo, Veronica...
Neuro-Oncology.  24 (2022)  Supplement_7 - p. vii76-vii76 , 2022
Link: https://doi.org/10.1093/..
 
?
9

PPM1D mutations are oncogenic drivers of de novo diffuse mi..:

Khadka, Prasidda ; Reitman, Zachary J. ; Lu, Sophie...
Nature Communications.  13 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
10

DIPG-54. p53 pathway reactivation as a therapeutic strategy..:

Lupien, Leslie ; Rendo, Veronica ; Morin, Eric...
Neuro-Oncology.  24 (2022)  Supplement_1 - p. i31-i31 , 2022
Link: https://doi.org/10.1093/..
 
?
11

OMRT-6. Optimizing MDM2 inhibition for the treatment of hig..:

Rendo, Veronica ; Lupien, Leslie ; Khuu, Nicholas...
Neuro-Oncology Advances.  3 (2021)  Supplement_2 - p. ii8-ii8 , 2021
Link: https://doi.org/10.1093/..
 
?
12

Common and mutation specific phenotypes of KRAS and BRAF mu..:

Kundu, Snehangshu ; Ali, Muhammad Akhtar ; Handin, Niklas...
Journal of Experimental & Clinical Cancer Research.  40 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
13

DDRE-14. OPTIMIZING MDM2 INHIBITION FOR THE TREATMENT OF HI..:

Rendo, Veronica ; Lupien, Leslie ; Khuu, Nicholas...
Neuro-Oncology.  23 (2021)  Supplement_6 - p. vi77-vi77 , 2021
Link: https://doi.org/10.1093/..
 
?
14

Exploiting loss of heterozygosity for allele-selective colo..:

Rendo, Veronica ; Stoimenov, Ivaylo ; Mateus, André...
Nature Communications.  11 (2020)  1 - p. , 2020
Link: https://doi.org/10.1038/..
 
?
15

Targeting tumor vulnerabilities associated with loss of het..:

Rendo, Veronica ; Stoimenov, Ivaylo ; Sjöblom, Tobias
Molecular & Cellular Oncology.  7 (2020)  4 - p. 1759390 , 2020
Link: https://doi.org/10.1080/..
 
1-15